HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tait, J. F. Articles by Fujikawa, K. Search for Related Content PubMed PubMed Citation Articles by Tait, J. F. Articles by Fujikawa, K. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 262, Issue 24, 11651-11656, 08, 1987

Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI

JF Tait and K Fujikawa

We recently identified residues 185-224 of the light chain of human high molecular weight kininogen (HMWK) as the binding site for plasma prekallikrein (Tait, J.F., and Fujikawa, K. (1986) J. Biol. Chem. 261, 15396-15401). In the present study, we have further defined the primary structure requirements for binding of HMWK to factor XI and prekallikrein. In a competitive fluorescence polarization binding assay, a 31-residue synthetic peptide (residues 194-224 of the HMWK light chain) bound to prekallikrein with a Kd of 20 +/- 6 nM, indistinguishable from the previously determined value of 18 +/- 5 nM for the light chain. We also prepared three shorter synthetic peptides corresponding to different portions of the 31-residue peptide (residues 205-224, 212-224, and 194-211), but these peptides bound to prekallikrein more than 100-fold more weakly. Factor XI also bound to the same region of the HMWK light chain, but at least 58 residues (185- 242) were required for optimal binding (Kd = 69 +/- 4 nM for the light chain; Kd = 130 +/- 50 nM for residues 185-242). The four synthetic peptides inhibited kaolin-activated clotting of blood plasma with potencies paralleling their affinities for prekallikrein and factor XI. Peptide 194-224 can also be used for rapid affinity purification of prekallikrein and factor XI from plasma.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. G. Shesely, C.-B. Hu, F. Alhenc-Gelas, P. Meneton, and O. A. Carretero A second expressed kininogen gene in mice Physiol Genomics, September 14, 2006; 26(2): 152 - 157. [Abstract] [Full Text] [PDF]

				M. Kawasaki, T. Maeda, K. Hanasawa, I. Ohkubo, and T. Tani Effect of His-Gly-Lys Motif Derived from Domain 5 of High Molecular Weight Kininogen on Suppression of Cancer Metastasis Both in Vitro and in Vivo J. Biol. Chem., December 5, 2003; 278(49): 49301 - 49307. [Abstract] [Full Text] [PDF]

				Y. Krijanovski, V. Proulle, F. Mahdi, M. Dreyfus, W. Muller-Esterl, and A. H. Schmaier Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression Blood, June 1, 2003; 101(11): 4430 - 4436. [Abstract] [Full Text] [PDF]

				T. R. Baird and P. N. Walsh Factor XI, but Not Prekallikrein, Blocks High Molecular Weight Kininogen Binding to Human Umbilical Vein Endothelial Cells J. Biol. Chem., May 30, 2003; 278(23): 20618 - 20623. [Abstract] [Full Text] [PDF]

				T. Chavakis, N. Boeckel, S. Santoso, R. Voss, I. Isordia-Salas, R. A. Pixley, E. Morgenstern, R. W. Colman, and K. T. Preissner Inhibition of Platelet Adhesion and Aggregation by a Defined Region (Gly-486-Lys-502) of High Molecular Weight Kininogen J. Biol. Chem., June 21, 2002; 277(26): 23157 - 23164. [Abstract] [Full Text] [PDF]

				T. Renne, D. Gailani, J. C. M. Meijers, and W. Muller-Esterl Characterization of the H-kininogen-binding Site on Factor XI. A COMPARISON OF FACTOR XI AND PLASMA PREKALLIKREIN J. Biol. Chem., February 8, 2002; 277(7): 4892 - 4899. [Abstract] [Full Text] [PDF]

				T. Chavakis, S. M. Kanse, F. Lupu, H.-P. Hammes, W. Muller-Esterl, R. A. Pixley, R. W. Colman, and K. T. Preissner Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions Blood, July 15, 2000; 96(2): 514 - 522. [Abstract] [Full Text] [PDF]

				R. W. Colman, B. A. Jameson, Y. Lin, D. Johnson, and S. A. Mousa Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis Blood, January 15, 2000; 95(2): 543 - 550. [Abstract] [Full Text] [PDF]

				T. Renne, J. Dedio, J. C. M. Meijers, D. Chung, and W. Muller-Esterl Mapping of the Discontinuous H-kininogen Binding Site of Plasma Prekallikrein. EVIDENCE FOR A CRITICAL ROLE OF APPLE DOMAIN-2 J. Biol. Chem., September 3, 1999; 274(36): 25777 - 25784. [Abstract] [Full Text] [PDF]

				M. M. H. Khan, S. P. Kunapuli, Y. Lin, A. Majluf-Cruz, R. A. D. Cadena, S. L. Cooper, and R. W. Colman Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H145 - H150. [Abstract] [Full Text] [PDF]

				R. W. Colman and A. H. Schmaier Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes Blood, November 15, 1997; 90(10): 3819 - 3843. [Full Text] [PDF]

				Y. Lin, R. B. Harris, W. Yan, K. R. McCrae, H. Zhang, and R. W. Colman High Molecular Weight Kininogen Peptides Inhibit the Formation of Kallikrein on Endothelial Cell Surfaces and Subsequent Urokinase-Dependent Plasmin Formation Blood, July 15, 1997; 90(2): 690 - 697. [Abstract] [Full Text] [PDF]

				H. Herwald, J. Dedio, R. Kellner, M. Loos, and W. Muller-Esterl Isolation and Characterization of the Kininogen-binding Protein p33 from Endothelial Cells. IDENTITY WITH THE gC1q RECEPTOR J. Biol. Chem., May 31, 1996; 271(22): 13040 - 13047. [Abstract] [Full Text] [PDF]

				H. Herwald, T. Renne, J. C. M. Meijers, D. W. Chung, J. D. Page, R. W. Colman, and W. Muller-Esterl Mapping of the Discontinuous Kininogen Binding Site of Prekallikrein. A DISTAL BINDING SEGMENT IS LOCATED IN THE HEAVY CHAIN DOMAIN A4 J. Biol. Chem., May 31, 1996; 271(22): 13061 - 13067. [Abstract] [Full Text] [PDF]

				S. P. Kunapuli, H. N. Bradford, B. A. Jameson, R. A. D. Cadena, L. Rick, R. P. Wassell, and R. W. Colman Thrombin-induced Platelet Aggregation Is Inhibited by the Heptapeptide Leu[IMAGE]-Ala[IMAGE] of Domain 3 in the Heavy Chain of High Molecular Weight Kininogen J. Biol. Chem., May 10, 1996; 271(19): 11228 - 11235. [Abstract] [Full Text] [PDF]

				A. A. K. Hasan, D. B. Cines, H. Herwald, A. H. Schmaier, and W. Müller-Esterl Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 J. Biol. Chem., August 18, 1995; 270(33): 19256 - 19261. [Abstract] [Full Text] [PDF]

				J. Ohnishi, T. Kihara, T. Hamabata, K. Takahashi, and T. Takahashi Cleavage Specificity of Porcine Follipsin J. Biol. Chem., August 18, 1995; 270(33): 19391 - 19394. [Abstract] [Full Text] [PDF]

				D. H. Ho, K. Badellino, F. A. Baglia, M.-F. Sun, M.-M. Zhao, D. Gailani, and P. N. Walsh The Role of High Molecular Weight Kininogen and Prothrombin as Cofactors in the Binding of Factor XI A3 Domain to the Platelet Surface J. Biol. Chem., August 11, 2000; 275(33): 25139 - 25145. [Abstract] [Full Text] [PDF]